Q1 2017 Apricus Biosciences Inc Earnings Call
Conference Call Apricus Biosciences Inc
Apricus Biosciences Inc Conference call or earnings call will be held on May 11, 2017 via an 800 number (toll-free). During the earnings conference call's session Apricus Biosciences Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Apricus Biosciences Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a Nevada corporation that was initially formed in 1987. We have operated in the pharmaceutical industry since 1995. Our current focus is on the development and commercialization of innovative products and product candidates in the areas of urology and rheumatology. Our proprietary drug delivery technology is a permeation enhancer called NexACT®. We have two product candidates in Phase 2 development, fispemifene for the treatment of symptomatic male secondary hypogonadism and RayVa(TM) for the treatment of Raynaud's phenomenon, secondary to scleroderma. We have one commercial product, Vitaros® for the treatment of erectile dysfunction ("ED"), which is currently in development in the United States, approved in Canada and marketed throughout Europe.Read more Conference Call